CCR5 Ligands in HIV Vaccines
The process is initiated by the annealing of an oligonucleotide primer (designated P1) to the RNA target present in the nucleic acid extract obtained from the test sample. The 3' end of the P1 primer is complimentary to the target analyte; the 5' end encodes the T7 RNA polymerase promoter. After annealing, the reverse transcriptase activity of AMV-RT is engaged and a cDNA copy of the RNA target is produced. The RNA portion of the resulting hybrid molecule is hydrolyzed through the action of RNase H. This permits the second primer (P2; sense), which is complimentary to an upstream portion of the RNA target, to anneal to the cDNA strand. This permits the DNAdependent DNA polymerase activity of AMV-RT to be engaged, producing a double stranded cDNA copy of the original RNA analyte with a functional T7 RNA polymerase promoter at one end. This promoter is then recognized by the T7 RNA polymerase, which produces a large amount of anti-sense, single stranded RNA transcripts corresponding to the original RNA target. These anti-sense RNA transcripts can then serve as templates for the amplification process, however the primers anneal in the reverse order. The entire NASBA process is conducted at 41~C, and the typical level of amplification is a factor of 109. For DNA, the process is the same except that an initial heat-denaturing step is required before the addition of the enzymes to the reaction mix (100~C, 5 minutes). There are several important characteristics of the NASBA process that are highly relevant to this proposal. First, the process is completely isothermal, and therefore does not require temperature cycling instrumentation. The reaction only requires incubation at 41 ~C. thus the process is specific for the amplification of RNA transcripts in a background of cellular DNA which encodes those same transcripts. This DNA can not serve as a template in the RNA amplification process, as is possible with a PCR based method. A second important feature is the fact that the product of the NASBA amplification reaction is single stranded RNA. As a single stranded amplicon, it can be subjected to hybridization-based detection methods without the need for a denaturing step (as would be needed with the DNA amplicons generated by RT-PCR). Further, RNA is far Jess stable than DNA. Therefore, the likelihood of amplicons functioning as contaminants in future reactions is extremely small. This is another important feature of an amplification assay that will be conducted under field conditions. Lastly, reverse transcriptase is incorporated directly into the amplification process. There is no dependence on a preliminary and independent conversion of an RNA analyte into a DNA intermediate. Samples needed for these studies. Ideally, we would like to receive about 25 x 106 cells (or an amount of blood that would allow to obtain the same amount of cells) from up to 40 subjects per arm of studies HVTN 039 and HTVNET 041; cells should be both pre and post immunization. Ideally we would like to follow subjects in time (obtaining samples every six months for example). However, exact number of samples and timing of withdrawal will depend on study design and availability, and it will be worked out with the HVTN Lab Science Committee. 9
About this Item
- Title
- CCR5 Ligands in HIV Vaccines
- Author
- Garzino-Demo, Alfredo
- Canvas
- Page 9
- Publication
- undated
- Subject terms
- proposals
- Series/Folder Title
- Scientific Research > Virology > Chemokines > General
- Item type:
- proposals
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0230.031
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0230.031/10
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0230.031
Cite this Item
- Full citation
-
"CCR5 Ligands in HIV Vaccines." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0230.031. University of Michigan Library Digital Collections. Accessed May 11, 2025.